Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.34 -0.07 (-0.21%)
At close: Nov 11, 2026 · 4:00 PM EST

Lakefront Biotherapeutics (LKFT) Gains from Sales and Divestitures (2016)

Updated

Lakefront Biotherapeutics (LKFT) posted Gains from Sales and Divestitures of $93,625 for the year ended Dec 31, 2020, compared with -$2,214 a year earlier.

Analysis

Lakefront Biotherapeutics (LKFT) Gains from Sales and Divestitures (2016) Analysis & Trends

Since the year ended Dec 31, 2015, Lakefront Biotherapeutics has reported Gains from Sales and Divestitures for 5 years.

  • The figure for the year ended Dec 31, 2020 stands as the highest annual Gains from Sales and Divestitures in data going back to the year ended Dec 31, 2015.
  • Business Quant data shows LKFT's Gains from Sales and Divestitures at -$2,214 in the year ended Dec 31, 2019, -$789,129 in the year ended Dec 31, 2018 and -$15.5 million in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lakefront Biotherapeutics 2.20 Bn 2.20 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 -14,339.16
API Access

Lakefront Biotherapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LKFT&period=max&api_key=YOUR_API_KEY